At 9.7% CAGR, Aircraft Communication System Market Share Worth $13.06 Bn, Globally, by 2028 - Exclusive Report by The Insight Partners
February 01, 2023 07:18 ET
|
The Insight Partners
New York, Feb. 01, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, Aircraft Communication System Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (VHF/UHF/HF Radios,...
Cardiac Monitoring Devices Market Size Worth $43.33Bn, Globally, by 2028 at 6.4% CAGR - Exclusive Report by The Insight Partners
April 01, 2022 05:37 ET
|
The Insight Partners
New York, April 01, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Cardiac Monitoring Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type...
Clinical Data Evaluating Gencaro for the Treatment of Atrial Fibrillation in Heart Failure Patients Featured in Three Presentations at the 2020 Heart Rhythm Scientific Sessions
May 07, 2020 08:30 ET
|
ARCA biopharma, Inc.
New data provide additional evidence of efficacy for Gencaro compared to active control in a pharmacogenetically-defined HF population at risk for AF recurrence ° 26% reduction in total time spent...
ARCA Biopharma Announces First Quarter 2020 Financial Results And Provides Corporate Update
May 06, 2020 16:30 ET
|
ARCA biopharma, Inc.
U.S. FDA Special Protocol Assessment agreement for PRECISION-AF, a single pivotal Phase 3 clinical trial of genetically targeted GencaroPRECISION-AF trial to evaluate Gencaro as a potential treatment...
ARCA biopharma Announces Fiscal Year 2019 Financial Results and Provides Corporate Update
February 18, 2020 16:30 ET
|
ARCA biopharma, Inc.
U.S. FDA Special Protocol Assessment agreement for a single pivotal Phase 3 clinical trial (PRECISION-AF) of genetically-targeted GencaroPRECISION-AF clinical trial initiation anticipated fourth...
ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium
September 12, 2019 08:30 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Sept. 12, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific Meeting
September 11, 2019 08:30 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Sept. 11, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of HF, WCG, and STI of Class Action Lawsuits Filed
June 06, 2019 12:13 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., June 06, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. reminds investors that it has commenced class action lawsuits against the following companies: HFF, Inc. (NYSE: HF) ...
Rigrodsky & Long, P.A. Files Class Action Suit Against HFF, Inc.
May 10, 2019 18:05 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., May 10, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court...
MSL, HOFD, and HF SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
May 01, 2019 13:44 ET
|
Rigrodsky & Long, P.A.
WILMINGTON, Del., May 01, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: MidSouth Bancorp, Inc. (NYSE: MSL) regarding possible violations of law related to...